206 related articles for article (PubMed ID: 34051741)
1. Haemochromatosis in a kidney transplant recipient: a case report.
Zakrocka I; Baranowicz-Gąszczyk I; Załuska W
BMC Nephrol; 2021 May; 22(1):201. PubMed ID: 34051741
[TBL] [Abstract][Full Text] [Related]
2. Rusfertide for the treatment of iron overload in HFE-related haemochromatosis: an open-label, multicentre, proof-of-concept phase 2 trial.
Kowdley KV; Modi NB; Peltekian K; Vierling JM; Ferris C; Valone FH; Gupta S
Lancet Gastroenterol Hepatol; 2023 Dec; 8(12):1118-1128. PubMed ID: 37863080
[TBL] [Abstract][Full Text] [Related]
3. Heterozygous recipient and donor HFE mutations associated with a hereditary haemochromatosis phenotype after liver transplantation.
Wigg AJ; Harley H; Casey G
Gut; 2003 Mar; 52(3):433-5. PubMed ID: 12584229
[TBL] [Abstract][Full Text] [Related]
4. Transient elevation of serum ferritin in a Sri Lankan with homozygosity for H63D mutation in the HFE gene: a case report.
Wickramasinghe W; Karunathilaka C; Jayasinghe S; Gooneratne L
J Med Case Rep; 2020 Jul; 14(1):93. PubMed ID: 32641120
[TBL] [Abstract][Full Text] [Related]
5. [Diagnosis of 5 patients with possible primary hemochromatosis].
Jacobs EM; de Vries RA; Elving LD; Stalenhoef AF; Swinkels DW
Ned Tijdschr Geneeskd; 2003 Apr; 147(14):666-70. PubMed ID: 12712652
[TBL] [Abstract][Full Text] [Related]
6. Mild iron overload in patients carrying the HFE S65C gene mutation: a retrospective study in patients with suspected iron overload and healthy controls.
Holmström P; Marmur J; Eggertsen G; Gåfvels M; Stål P
Gut; 2002 Nov; 51(5):723-30. PubMed ID: 12377814
[TBL] [Abstract][Full Text] [Related]
7. Testing for haemochromatosis in a liver clinic population: relationship between ethnic origin, HFE gene mutations, liver histology and serum iron markers.
Moodie SJ; Ang L; Stenner JM; Finlayson C; Khotari A; Levin GE; Maxwell JD
Eur J Gastroenterol Hepatol; 2002 Mar; 14(3):223-9. PubMed ID: 11953685
[TBL] [Abstract][Full Text] [Related]
8. Compound heterozygosity for haemochromatosis gene mutations and hepatic iron overload in allogeneic bone marrow transplant recipients.
Grigg AP; Bhathal PS
Pathology; 2001 Feb; 33(1):44-9. PubMed ID: 11280607
[TBL] [Abstract][Full Text] [Related]
9. Review article: haemochromatosis.
Whittington CA; Kowdley KV
Aliment Pharmacol Ther; 2002 Dec; 16(12):1963-75. PubMed ID: 12452931
[TBL] [Abstract][Full Text] [Related]
10. Haemochromatosis.
Adams PC; Barton JC
Lancet; 2007 Dec; 370(9602):1855-60. PubMed ID: 18061062
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic venesection at the Australian Red Cross Blood Service: impact of the High Ferritin Application on management of hereditary haemochromatosis.
Bentley P; Bell B; Olynyk J
Aust Fam Physician; 2015 Aug; 44(8):589-92. PubMed ID: 26510149
[TBL] [Abstract][Full Text] [Related]
12. GNPAT variant (D519G) is not associated with an elevated serum ferritin or iron removed by phlebotomy in patients referred for C282Y-linked hemochromatosis.
Levstik A; Stuart A; Adams PC
Ann Hepatol; 2016 Nov-Dec 2016; 15(6):907-910. PubMed ID: 27740525
[TBL] [Abstract][Full Text] [Related]
13. Serum prohepcidin concentration: no association with iron absorption in healthy men; and no relationship with iron status in men carrying HFE mutations, hereditary haemochromatosis patients undergoing phlebotomy treatment, or pregnant women.
Roe MA; Spinks C; Heath AL; Harvey LJ; Foxall R; Wimperis J; Wolf C; Fairweather-Tait SJ
Br J Nutr; 2007 Mar; 97(3):544-9. PubMed ID: 17313717
[TBL] [Abstract][Full Text] [Related]
14. HFE mutations, iron deficiency and overload in 10,500 blood donors.
Jackson HA; Carter K; Darke C; Guttridge MG; Ravine D; Hutton RD; Napier JA; Worwood M
Br J Haematol; 2001 Aug; 114(2):474-84. PubMed ID: 11529872
[TBL] [Abstract][Full Text] [Related]
15. Haptoglobin type neither influences iron accumulation in normal subjects nor predicts clinical presentation in HFE C282Y haemochromatosis: phenotype and genotype analysis.
Carter K; Bowen DJ; McCune CA; Worwood M
Br J Haematol; 2003 Jul; 122(2):326-32. PubMed ID: 12846904
[TBL] [Abstract][Full Text] [Related]
16. Iron-overload and genotypic expression of HFE mutations H63D/C282Y and transferrin receptor Hin6I and BanI polymorphism in german patients with hereditary haemochromatosis.
Gottschalk R; Seidl C; Schilling S; Braner A; Seifried E; Hoelzer D; Kaltwasser JP
Eur J Immunogenet; 2000 Jun; 27(3):129-34. PubMed ID: 10940080
[TBL] [Abstract][Full Text] [Related]
17. High prevalence of non-HFE gene-associated haemochromatosis in patients from southern Italy.
De Marco F; Liguori R; Giardina MG; D'Armiento M; Angelucci E; Lucariello A; Morante R; Cimino L; Galeota-Lanza A; Tarantino G; Ascione A; Budillon G; Vecchione R; Martinelli R; Matarazzo M; De Simone V
Clin Chem Lab Med; 2004 Jan; 42(1):17-24. PubMed ID: 15061375
[TBL] [Abstract][Full Text] [Related]
18. Reduction of body iron in HFE-related haemochromatosis and moderate iron overload (Mi-Iron): a multicentre, participant-blinded, randomised controlled trial.
Ong SY; Gurrin LC; Dolling L; Dixon J; Nicoll AJ; Wolthuizen M; Wood EM; Anderson GJ; Ramm GA; Allen KJ; Olynyk JK; Crawford D; Ramm LE; Gow P; Durrant S; Powell LW; Delatycki MB
Lancet Haematol; 2017 Dec; 4(12):e607-e614. PubMed ID: 29195602
[TBL] [Abstract][Full Text] [Related]
19. Frequency of the HFE C282Y and H63D mutations in Danish patients with clinical haemochromatosis initially diagnosed by phenotypic methods.
Milman N; Koefoed P; Pedersen P; Nielsen FC; Eiberg H
Eur J Haematol; 2003 Dec; 71(6):403-7. PubMed ID: 14703688
[TBL] [Abstract][Full Text] [Related]
20. [Diagnosis and treatment of primary hemochromatosis].
Swinkels DW; Marx JJ
Ned Tijdschr Geneeskd; 1999 Jul; 143(27):1404-8. PubMed ID: 10422553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
